CMND ▲ +2.5% - Clearmind Medicine Inc. $CMND - Clearmind Medicine Delivers Briefing to FDA Following Invitation to Historic Psychedelic Hearing in Washington, D.C. Clearmind Medicine shares rose 2.5% after the company announced it delivered a briefing to the FDA following an invitation to present at a historic psychedelic hearing in Washington, D.C. The hearing represents a significant regulatory milestone for the emerging psychedelic medicine sector, which likely boosted investor sentiment around the company's pipeline progress. 17-SEP-2026 07:42 AM ET